Belmont Global Advisors, Inc. - LA JOLLA PHARMACEUTICAL CO ownership

Quarter-by-quarter ownership
Belmont Global Advisors, Inc. ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2016$960,000
-8.1%
60,000
+20.0%
0.92%
-13.3%
Q1 2016$1,045,000
+3.2%
50,000
+33.3%
1.06%
-19.0%
Q4 2015$1,013,000
+4.1%
37,522
+7.2%
1.31%
-20.6%
Q3 2015$973,000
-20.6%
35,000
-30.0%
1.65%
+21.6%
Q2 2015$1,225,000
-61.0%
50,000
-70.9%
1.36%
-57.5%
Q1 2015$3,140,000
-8.1%
171,600
-7.3%
3.19%
-5.3%
Q4 2014$3,415,000
+67.7%
185,100
-12.6%
3.37%
+111.3%
Q3 2014$2,036,000
+64.3%
211,900
+57.0%
1.60%
+78.5%
Q2 2014$1,239,000
-38.0%
135,000
-27.0%
0.89%
-46.8%
Q1 2014$1,998,000185,0001.68%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q3 2023
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders